Boston Scientific Names Joseph Fitzgerald as COO

MT newswire2026/10/07 10:33

06:33 AM EDT, 10/07/2026 (MT Newswires) -- Boston Scientific (BSX) said Wednesday it appointed Joseph Fitzgerald as executive vice president and chief operating officer, effective Jan. 1, 2027. The company said Fitzgerald will oversee its global operations, business units and regions. Boston Scientific will also reorganize into three reporting segments, consisting of Interventional Therapies, Rhythm Solutions and MedSurg, it added. Lance Bates will lead Interventional Therapies, Nick Spadea-Anello will head Rhythm Solutions, and Stephen Morse will lead MedSurg and Asia Pacific, the company said, adding that all three will report to Fitzgerald. Fitzgerald currently serves as executive vice president and group president of Cardiovascular, Boston Scientific said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Can NEAR Protocol defend $4.30 support after a 10% price drop?

AMBCrypto•2026/10/25 01:00

Central banks are "buying up" ETFs, "attracting capital"—why is gold still falling?

新浪财经•2026/10/25 00:53

U.S. Consumer Index drops to 48.0

AiCoin•2026/10/25 00:34

Scott Bessent Calls GENIUS Act a ‘Watershed Moment’ as OCC Sets Stablecoin Rules

Cryptopotato•2026/10/24 19:33